TECH Bio-Techne
too hard · 66
Owner-earnings value$19.86
Price$72.47
Margin of safety
-72.6%
Quality gate · 66/100
⚠ sub-hurdle returns (median roic 7% < 9%)
Median ROIC7.3%
Gross margin65.8%
Net debt / EBITDA0.1x
FCF conversion137%
Share count / yr-0.3%
Profitable years4/4
Moat & management
Owner-earnings inputs
| Owner earnings (TTM) | 250.37M |
| Owner-earnings yield | 2.2% |
| Free-cash-flow yield | 2.3% |
| Growth used (normalized) | 2.2% |
| Market-implied growth (reverse DCF) | 25.0% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 11.0% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 256.00M | 2.2% | 230.56M |
| 2 | 261.96M | 2.3% | 212.50M |
| 3 | 268.28M | 2.4% | 196.00M |
| 4 | 274.98M | 2.5% | 180.94M |
| 5 | 282.08M | 2.6% | 167.17M |
| 6 | 289.60M | 2.7% | 154.58M |
| 7 | 297.56M | 2.7% | 143.05M |
| 8 | 305.99M | 2.8% | 132.49M |
| 9 | 314.91M | 2.9% | 122.80M |
| 10 | 324.36M | 3.0% | 113.92M |
Recent news
score · 8 articles
- 2 Cash-Producing Stocks Worth Investigating and 1 We Brush Off
- Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package
- Is Bio-Techne Stock Outperforming the Nasdaq?
- 3 Reasons to Sell TECH and 1 Stock to Buy Instead
- Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound
- Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
- Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks
- 1 Surging Stock for Long-Term Investors and 2 That Underwhelm
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~25%/yr owner-earnings growth over 10y (reverse DCF); model credits 2%.